Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Shuanglong Pharmaceutical is a China-based pharmaceutical company specializing in the development, production, and distribution of Traditional Chinese Medicine (TCM) and chemical drug formulations. Located in the Wuhan Economic and Technological Development Zone, the company operates modern manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards. Its product portfolio includes a variety of dosage forms such as tablets, capsules, and granules, targeting therapeutic areas like respiratory health, cardiovascular support, and digestive care. The company focuses on integrating traditional herbal wisdom with modern pharmaceutical technology to serve the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Shuanglong Pharmaceutical.